Trademark: 79280356
Word
MIDATECH PHARMA
Status Date
Tuesday, February 9, 2021
Registration Number
6263411
Registration Date
Tuesday, February 9, 2021
Filing Date
Thursday, November 14, 2019
Published for Opposition
Tuesday, November 24, 2020
1 Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; nano-particle ingredients for use in pharmaceuticals, medicines and medicated cosmetics for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
5 Pharmaceutical preparations and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles
40 Custom manufacture of nano-particles for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
42 Scientific research services for others in the field of nano-particle technology; pharmaceutical and drug development and drug discovery services; scientific laboratory services, namely, testing, efficiency evaluation and advisory services in the field of nano-particles and nano-medicine; scientific laboratory services, namely, testing, efficiency and technical and scientific advisory services in the field of pharmaceuticals; scientific research laboratory services, namely, nano-particle laboratory services
The color(s) blue is/are claimed as a feature of the mark.
"PHARMA"
The mark consists of the wording "MIDATECH" in dark blue above the wording "PHARMA" in light blue. Next to the wording starts an incomplete circular array of light and blue dots that bend towards the letter "E" in "MIDATECH". White appearing in the mark is background and not claimed as a feature of the mark.
Jun 7, 2021
Final Decision Transaction Processed By Ib
May 12, 2021
Final Disposition Notice Sent To Ib
May 12, 2021
Final Disposition Processed
May 9, 2021
Final Disposition Notice Created, To Be Sent To Ib
Feb 9, 2021
Registered-Principal Register
Dec 6, 2020
Notification Processed By Ib
Nov 24, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 24, 2020
Published For Opposition
Nov 18, 2020
Notification Of Possible Opposition Sent To Ib
Nov 18, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Nov 4, 2020
Notification Of Notice Of Publication E-Mailed
Oct 16, 2020
Approved For Pub - Principal Register
Sep 23, 2020
Teas/Email Correspondence Entered
Sep 23, 2020
Correspondence Received In Law Office
Sep 23, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 23, 2020
Teas Change Of Correspondence Received
Sep 23, 2020
Teas Change Of Domestic Representatives Address
Sep 23, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 23, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 23, 2020
Teas Change Of Owner Address Received
Sep 23, 2020
Teas Response To Office Action Received
Apr 18, 2020
Refusal Processed By Ib
Mar 28, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 27, 2020
Refusal Processed By Mpu
Mar 17, 2020
Application Filing Receipt Mailed
Mar 12, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Mar 11, 2020
Non-Final Action Written
Mar 11, 2020
Assigned To Examiner
Mar 11, 2020
New Application Office Supplied Data Entered In Tram
Mar 5, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
